Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
Collections open for submissions
- Phase I clinical trials
- Latest updates from major conferences
- New developments in delivery technology, materials, and molecular engineering for drug discovery
Phase I clinical trials
This Journal of Hematology & Oncology and Experimental Hematology & Oncology series invites submissions for the collection of research, review, and correspondence articles dedicated to Phase I clinical trials in the fields of either oncology or hematology. Join us in shaping the future of early-phase clinical research and accelerating the translation of promising therapies from bench to bedside.
Latest updates from major conferences
This Journal of Hematology & Oncology and Experimental Hematology & Oncology series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference.
weyo / stock.adobe.com
New developments in delivery technology, materials, and molecular engineering for drug discovery
This series covers new technology, materials, and models for drug discovery. Development and applications of organoids, 3D cultures, PDX modes, nano-molecules, AI technology, and single-cell maps for drug discovery will be the focus.
Aims and scope
Articles
-
-
Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China’s responses to address secondary cancer risks of CAR-T therapy
-
Targeting GPRC5D for multiple myeloma therapy
-
Landscape of biallelic DNMT3A mutant myeloid neoplasms
-
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients
-
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
-
The effects of β-glucan on human immune and cancer cells
-
The diagnosis and management of NK/T-cell lymphomas
-
NK cell-based cancer immunotherapy: from basic biology to clinical development
-
Wnt/beta-catenin pathway: modulating anticancer immune response
Colorectal Cancer Awareness Month
In recognition of Colorectal Cancer Awareness Month this March, we have selected a collection of articles on colorectal cancer from across our open access portfolio. Together, these articles contribute to the evolving landscape of colorectal cancer research and the fight against this prevalent and impactful disease.
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology.
CAHON: Stop hate crimes and racism
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
Editor's quote
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
-
Official journal of
-
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Instructions for authors
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 29.5
5-year Journal Impact Factor: 26.9
Source Normalized Impact per Paper (SNIP): 4.489
SCImago Journal Rank (SJR): 7.522Speed 2023
Submission to first editorial decision (median days): 4
Submission to acceptance (median days): 59Usage 2023
Downloads: 3,173,795
Altmetric mentions: 2,671
On the blog
-
-
Winners of the 2022 Cardio-Oncology Journal Prize
06 April 2023
-
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).